Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products

Products

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC1745 Desmethyl Mk-6884
Precursor for PET imaging 11C-radiolabeled MK-6884
More description
DCC1744 Desfluoro Ezetimibe
Desfluoro impurity of Ezetimibe
More description
DCC1743 Deramciclane Fumarate
Inhibitor of acetyl-CoA carboxylase (ACC), activating GPR40, inhibiting West Nile virus (WNV) infection and reducing the multiplication of Usutu virus (USUV), a WNV-related flavivirus
More description
DCC1742 Dequalinium Bromide
HIV-1 fusion inhibitor, targeting the membrane-proximal external region of Env spikes, specifically inhibiting the HIV-1 envelope-mediated membrane fusion by blocking CD4-induced conformational changes
More description
DCC1741 Depmpo
Most efficient spin trap for the in vitro and in vivo detection of O-, N-, S- and C-centered free radicals
More description
DCC1740 Deoxynybomycin
Selective anti-tumor agent, inducing apoptosis and inhibiting topoisomerase I
More description
DCC1739 Deoxy-dalsir
Novel selective and sensitive near-infrared fluorescent probe for visualization of endogenous nitric oxide in living cells and animals
More description
DCC1738 Deox B 7,4
Novel reversible microtubule inhibitor, increasing lysosomal V-ATPase activity and lysosome acidity
More description
DCC1737 Denv2-in-3
Novel selective inhibitor of the DENV2 protease, inhibiting flavivirus protease through targeted covalent modification of active site serine, contrary to an allosteric binding mechanism as previously described
More description
DCC1736 Denv2-in-2
Novel selective inhibitor of the DENV2 protease, inhibiting flavivirus protease through targeted covalent modification of active site serine, contrary to an allosteric binding mechanism as previously described
More description
DCC1735 Denv2-in-1
Novel selective inhibitor of the DENV2 protease, inhibiting flavivirus protease through targeted covalent modification of active site serine, contrary to an allosteric binding mechanism as previously described
More description
DCC1734 Denosomin
Novel anti-Alzheimer's disease agent, ameliorates spinal cord injury via axonal growth associated with astrocyte-secreted vimentin
More description
DCC1733 Denaverine Hydrochloride
Antispasmodic agent, improving the elasticity of the soft birth canal and regulating labor contractions
More description
DCC1732 Denagliptin Tosylate
Selective DPP-IV Inhibitor
More description
DCC1731 Demethoxyviridin
Potent inhibitor of PI3 kinases
More description
DCC1730 Delta-tocopherol
Vitamin E variant, inhibiting prostate adenocarcinoma, lung tumorigenesis, promoting thermogenic gene expression via PGC-1α upregulation, preventing methylglyoxal-induced apoptosis by reducing ROS generation and inhibiting apoptotic signaling cascades
More description
DCC1729 Delcasertib
Novel selective δ-protein kinase C inhibitor
More description
DCC1728 Dehydrorabelomycin
Natural polyketide matabolite
More description
DCC1727 Degrader Bt1
Novel selective degrader of BCR-ABL over c-ABL in leukemia cancer cells
More description
DCC1726 Deferoxamine Hydrochloride
Iron chelating agent, chelating iron from intra-lysosomal ferritin and hemosiderin forming ferrioxamine, a water-soluble chelate excreted by the kidneys and in the feces via the bile
More description
DCC1725 Deferasirox Ferrate(iii) Tripotassium Complex
Deferasirox iron complex
More description
DCC1724 Debio-1452-nh3
Novel potent inhibitor of the enoyl-acyl carrier protein reductase FabI, reducing bacterial burden in mice and rescuing mice from lethal infections with clinical isolates of Acinetobacter baumannii, Klebsiella pneumoniae and E. coli
More description
DCC1723 Deac-pda-atp
Fluorophore to myosin or actomyosin
More description
DCC1722 Deacm-caged D-luciferin
Coumarin-caged D-luciferin, being excited in the caged group only by light of wavelength ranging within 400-430 nm
More description
DCC1721 Dea Nonoate Sodium Salt
NO donor, generating a controlled release of nitric oxide in solution.
More description
DCC1720 Ddr-trk-1n
Negative control for DDR-TRK-1
More description
DCC1719 Ddri-18
Inhibitor of nonhomologous end-joining (NHEJ) DNA repair following double strand DNA breaks induced by ionizing radiation, enhancing the effects of DNA-damaging cancer drugs like etoposide, camptothecin and doxorubicin
More description
DCC1718 Ddr1-in-2
Potent and selective DDR1 receptor tyrosine kinase inhibitor
More description
DCC1717 ddpm-1457
Potent mGAT4 inhibitor
More description
DCC1716 Ddo-7204
Novel Nrf2 activator
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X